Gibtulio SM 10/1000 Tablet 10's
Rs. 164.52
Title
Gibtulio SM 10/1000 Tablet 10's
Prescription drug
Expiry
:
31-05-2027
About: Gibtulio‑SM 10/1000 is a triple‑action antidiabetic tablet for adults with type 2 diabetes inadequately controlled on dual therapy.
Usage Instructions: Generally one tablet daily with meals as directed.
Benefits: Lowers HbA1c by targeting glucose production, insulin response, and urinary glucose excretion.
How it Works: Combines empagliflozin (SGLT2 inhibitor), metformin (biguanide), and sitagliptin (DPP‑4 inhibitor) for complementary glycemic control.
Side Effects: Genital infections, urinary infections, GI upset, and hypoglycemia (especially with other antidiabetics).
Safety Advice: Not recommended in severe renal impairment; monitor renal function, hydration, and blood glucose regularly.
Storage: Store in a cool, dry place away from sunlight.
Usage Instructions: Generally one tablet daily with meals as directed.
Benefits: Lowers HbA1c by targeting glucose production, insulin response, and urinary glucose excretion.
How it Works: Combines empagliflozin (SGLT2 inhibitor), metformin (biguanide), and sitagliptin (DPP‑4 inhibitor) for complementary glycemic control.
Side Effects: Genital infections, urinary infections, GI upset, and hypoglycemia (especially with other antidiabetics).
Safety Advice: Not recommended in severe renal impairment; monitor renal function, hydration, and blood glucose regularly.
Storage: Store in a cool, dry place away from sunlight.
₹164.52
MRP: ₹182.80
Save ₹18.28
(10%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Gibtulio‑SM 10/1000 is a triple‑action antidiabetic tablet for adults with type 2 diabetes inadequately controlled on dual therapy.
Usage Instructions: Generally one tablet daily with meals as directed.
Benefits: Lowers HbA1c by targeting glucose production, insulin response, and urinary glucose excretion.
How it Works: Combines empagliflozin (SGLT2 inhibitor), metformin (biguanide), and sitagliptin (DPP‑4 inhibitor) for complementary glycemic control.
Side Effects: Genital infections, urinary infections, GI upset, and hypoglycemia (especially with other antidiabetics).
Safety Advice: Not recommended in severe renal impairment; monitor renal function, hydration, and blood glucose regularly.
Storage: Store in a cool, dry place away from sunlight.
Usage Instructions: Generally one tablet daily with meals as directed.
Benefits: Lowers HbA1c by targeting glucose production, insulin response, and urinary glucose excretion.
How it Works: Combines empagliflozin (SGLT2 inhibitor), metformin (biguanide), and sitagliptin (DPP‑4 inhibitor) for complementary glycemic control.
Side Effects: Genital infections, urinary infections, GI upset, and hypoglycemia (especially with other antidiabetics).
Safety Advice: Not recommended in severe renal impairment; monitor renal function, hydration, and blood glucose regularly.
Storage: Store in a cool, dry place away from sunlight.